PP 65 Are GSK2118436 and GSK1120212 effective in melanoma cell lines harboring V600BRAF mutations different from the common V600EBRAF variant?

Title
PP 65 Are GSK2118436 and GSK1120212 effective in melanoma cell lines harboring V600BRAF mutations different from the common V600EBRAF variant?
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CANCER
Volume 47, Issue -, Pages S11
Publisher
Elsevier BV
Online
2011-11-24
DOI
10.1016/s0959-8049(11)72628-4

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started